Stock NLSP NLS PHARMACEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. NLS Pharmaceutics Ltd.

Equities

NLSP

CH0523961370

Delayed Nasdaq
Other stock markets
 01:59:28 2024-04-24 pm EDT 		5-day change 1st Jan Change
0.1268 USD -2.61% Intraday chart for NLS Pharmaceutics Ltd. -2.93% -78.11%
Apr. 08 Nls Pharmaceutics Ltd. Announces Resignation of Anthony S. Walsh as A Member of the Board of Directors CI
Apr. 03 NLS Pharmaceutics Ltd. announced that it has received $1.75 million in funding CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Maxim Downgrades NLS Pharmaceutics to Hold From Buy
MT
Maxim Upgrades NLS Pharmaceutics to Buy From Hold, Price Target is $4
MT
Maxim Downgrades NLS Pharmaceutics to Hold From Buy
MT
Laidlaw Starts NLS Pharmaceutics at Buy With $6 Price Target
MT
Alliance Global Initiates Coverage on NLS Pharmaceutics With Buy Rating
MT
NLS PHARMACEUTICS : Brookline Capital Initiates Coverage on NLS Pharmaceutics AG With Buy Rating, $12 Price Target
MT
NLS PHARMACEUTICS : Maxim Initiates Coverage on NLS Pharmaceutics at Buy With $8 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NLSP Stock
  4. News NLS Pharmaceutics Ltd.
  5. Analyst Reco.